The CASE for Hemispherx Biopharma. DRUGS for the gambler! - Motley Fool

The CASE for Hemispherx Biopharma. DRUGS for the gambler! Motley Fool Is it a cure for the gout, arthritis, or a Cialis replacement? I really don't know, but it's popping and I'm riding. We will see what's left when this one deflates. I lucked out on a small portion of DNDN. I lost out on Northfield Laboratories (NFLD) ...

STOCKS NEWS US-US GDP data adds to hopes for global recovery - Forbes

STOCKS NEWS US-US GDP data adds to hopes for global recovery Forbes, NY The trade possibly closes out the call position while opening a similar long position in the line. straight day in the options market as its shares jumped 8.7 percent to 6.25. gout patients. Savient's biologics license application for Krystexxa ... STOCKS NEWS US-Option players send out bullish signals on Star Interactive Investor all 14 news articles

The Failed Promise of Innovation in the US - BusinessWeek

The Failed Promise of Innovation in the US BusinessWeek Scientific progress continued, the technologies have matured, and more innovations are coming to market—everything from the first gout treatment in 40 years to cloud computing, the long-ballyhooed phenomenon "information at your fingertips. ...

Readers' voice: May 21, 2009 - Charleston Gazette

Readers' voice: May 21, 2009 Charleston Gazette, WV I have rheumatoid arthritis and severe gout. I am on Medicaid. I wish the people would stop stereotyping people and saying they are lazy and do not work when you are unable to work. Many people need those benefits. I see flooding everywhere in the ...